Long-lasting inhibitors of the gastric H,K-ATPase
- 1 September 2009
- journal article
- Published by Taylor & Francis in Expert Review of Clinical Pharmacology
- Vol. 2 (5) , 461-468
Abstract
Proton pump inhibitors (PPIs) are acid-activated prodrugs that covalently bind to the gastric H,K-ATPase on its luminal surface. Only active pumps can be inhibited. The short plasma residence time ...Keywords
This publication has 18 references indexed in Scilit:
- Clinical trial: intragastric acid control in patients who have Barrett’s oesophagus—comparison of once‐ and twice‐daily regimens of esomeprazole and lansoprazoleAlimentary Pharmacology & Therapeutics, 2009
- Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolatesJournal of Clinical Pathology, 2008
- The Gastric H,K ATPase as a Drug TargetJournal of Clinical Gastroenterology, 2007
- Comparison of the effects of immediate‐release omeprazole oral suspension, delayed‐release lansoprazole capsules and delayed‐release esomeprazole capsules on nocturnal gastric acidity after bedtime dosing in patients with night‐time GERD symptomsAlimentary Pharmacology & Therapeutics, 2007
- The Effect of CYP2C19 Polymorphisms on H. pylori Eradication Rate in Dual and Triple First-Line PPI Therapies: A Meta-analysisAmerican Journal of Gastroenterology, 2006
- A comparative study of the early effects of tenatoprazole 40 mg and esomeprazole 40 mg on intragastric pH in healthy volunteersAlimentary Pharmacology & Therapeutics, 2005
- Tenatoprazole, a novel proton pump inhibitor with a prolonged plasma half‐life: effects on intragastric pH and comparison with esomeprazole in healthy volunteersAlimentary Pharmacology & Therapeutics, 2004
- Restoration of acid secretion following treatment with proton pump inhibitorsGastroenterology, 2002
- Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease.Gut, 1992
- Definition and Antagonism of Histamine H2-receptorsNature, 1972